$ONTO

ONTO INNOVATION INC.

No enriched coverage for $ONTO in the last 7 days.

No SEC Form 4 filings for $ONTO in the last 30 days.

See all $ONTO insider activity →
High

Onto Innovation (ONTO) Bets $720M on X-Ray Chip Technology

Onto Innovation (ONTO) acquired a 27% stake in Rigaku Holdings for $720M, expanding its X-ray chip tech collaboration. Q2 2026 revenue rose 35.3% YoY to $343.1M, beating guidance. Backlog exceeded $1B. Q3 guidance: $380M-$400M revenue, EPS $2.18-$2.38. H1 2026 net income fell to $93.9M from $98M YoY, with margins declining.

Weekly news roundup: AI memory race heats up, Taiwan manufacturing rebounds, Nexperia rift deepens

Taiwan's manufacturing indicator improved in July, driven by AI and semiconductor demand, though US export growth slowed. Nexperia's assets were frozen in a dispute with Wingtech. Sandisk introduced HBF for AI memory, while Micron plans to double HBM capacity. Samsung launched the Galaxy S26 FE. Marvell outlined silicon photonics growth, and Onto Innovation targeted AI chip process control.

Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally

Allegro MicroSystems (ALGM) reports 15% automotive revenue growth, 30% bookings increase. Onto Innovation (ONTO) posts $343M revenue, up 35% YOY, raises growth forecasts. Badger Meter (BMI) faces 7% sales decline but expects sequential improvement. All three companies are positioned in growth industries: EVs, chips, and water infrastructure.

ONTO sentiment & insider activity

Recent ONTO coverage spans market movers, financial news and mergers & acquisitions.

What's driving ONTO

AlphAI scores every news story that mentions ONTO with an AI model for sentiment and relevance, and aggregates insider trades from ONTO INNOVATION INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ONTO

Score
$ONTOHighAI 9/10

Onto Innovation (ONTO) Bets $720M on X-Ray Chip Technology

Onto Innovation (ONTO) acquired a 27% stake in Rigaku Holdings for $720M, expanding its X-ray chip tech collaboration. Q2 2026 revenue rose 35.3% YoY to $343.1M, beating guidance. Backlog exceeded $1B. Q3 guidance: $380M-$400M revenue, EPS $2.18-$2.38. H1 2026 net income fell to $93.9M from $98M YoY, with margins declining.

$MULow

Weekly news roundup: AI memory race heats up, Taiwan manufacturing rebounds, Nexperia rift deepens

Taiwan's manufacturing indicator improved in July, driven by AI and semiconductor demand, though US export growth slowed. Nexperia's assets were frozen in a dispute with Wingtech. Sandisk introduced HBF for AI memory, while Micron plans to double HBM capacity. Samsung launched the Galaxy S26 FE. Marvell outlined silicon photonics growth, and Onto Innovation targeted AI chip process control.

Onto Innovation Drops 6.9% Amid Sector

Onto Innovation Inc. shares fell 6.9% to $272.36 on Friday, part of a broader semiconductor equipment sector selloff. Peers like KLA Corp. and Teradyne also declined, with trading volume at 605,955 shares. The drop reflects sector-wide concerns, not company-specific issues, according to the report.

$MRVLMed

Stocks Mixed on Strength in Chipmakers vs Weakness in Software Companies

US stocks are mixed, with chipmakers and AI-infrastructure stocks rising, while software companies decline. Treasury Secretary Bessent announced upcoming economic measures against Iran. S&P 500 is tracking for 32% Q2 earnings growth, with 85% of companies beating estimates. Marvell (MRVL) and Sandisk (SNDK) lead gains, while Datadog (DDOG) and Salesforce (CRM) lead losses. Astera Labs (ALAB) and Onto Innovation (ONTO) received upgrades, while EyePoint (EYPT) plunged after a failed trial.

$SNDKMed

Stock Indices Waver on Strength in Chipmakers vs Weakness in Software Companies

Stock indices fluctuated as chipmakers rose while software companies declined. S&P 500 Q2 earnings are tracking at +32% growth, with AI infrastructure contributing 60%. Sandisk (SNDK) led gains, up +10%, while Datadog (DDOG) led losses, down -3%. EyePoint (EYPT) dropped -71% after a failed trial. Constellation Brands (STZ) fell -5% after Berkshire Hathaway sold its stake.

$LUNRMed

Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more

Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.

$ONTOLow

This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - P

Wall Street analysts initiated coverage on several stocks. Goldman Sachs started Onto Innovation (NYSE:ONTO) with a Buy rating and $400 target, versus a $331.71 close. Keefe, Bruyette & Woods began Columbia Financial (NASDAQ:CLBK) at Outperform, $14.5. Morgan Stanley started Target Hospitality (NASDAQ:TH) Overweight, $22. Piper Sandler began Dave (NASDAQ:DAVE) Overweight, $390. Needham started Pulse Biosciences (NASDAQ:PLSE) Buy, $58.

Day of Reckoning for Boston’s Lab Market

Greater Boston’s lab real estate boom has shifted to a glut, with brokers and lenders citing high vacancy and limited lab tenant demand. Alexandria Real Estate Equities is pursuing non-life-science uses, while Onto Innovation leased 160,000 sq ft at $17/sf. CBRE tracks 2.45M sq ft of lab demand vs 16.6M vacant. Mass General Brigham is reportedly taking space at 74M. BXP expects AI and office users to absorb some inventory; lenders may force more distressed sales.

Alexandria Lands 160K SF Tech HQ Lease in Andover

Alexandria Real Estate Equities leased nearly 160,000 sq ft at 3000 Minuteman Road in Andover to Onto Innovation for its global headquarters. The 13-year lease starts in 2027, with initial rent of $17 per sq ft, per an SEC filing. Alexandria said on an earnings call it is targeting tech tenants. Onto reported 2025 revenues of $1 billion.

Related tickers